105 related articles for article (PubMed ID: 17295779)
21. Brivanib alaninate, a dual inhibitor of vascular endothelial growth factor receptor and fibroblast growth factor receptor tyrosine kinases, induces growth inhibition in mouse models of human hepatocellular carcinoma.
Huynh H; Ngo VC; Fargnoli J; Ayers M; Soo KC; Koong HN; Thng CH; Ong HS; Chung A; Chow P; Pollock P; Byron S; Tran E
Clin Cancer Res; 2008 Oct; 14(19):6146-53. PubMed ID: 18829493
[TBL] [Abstract][Full Text] [Related]
22. Adenovirus vector expressing mda-7 selectively kills hepatocellular carcinoma cell line Hep3B.
Xue XB; Chen K; Wang CJ; Zheng JW; Yu Y; Peng ZH; Wu ZD
Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):509-14. PubMed ID: 18842498
[TBL] [Abstract][Full Text] [Related]
23. Epidermal growth factor receptor vIII enhances tumorigenicity and resistance to 5-fluorouracil in human hepatocellular carcinoma.
Wang H; Jiang H; Zhou M; Xu Z; Liu S; Shi B; Yao X; Yao M; Gu J; Li Z
Cancer Lett; 2009 Jun; 279(1):30-8. PubMed ID: 19217205
[TBL] [Abstract][Full Text] [Related]
24. Epidermal growth factor stimulates Rac activation through Src and phosphatidylinositol 3-kinase to promote colonic epithelial cell migration.
Dise RS; Frey MR; Whitehead RH; Polk DB
Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G276-85. PubMed ID: 17991704
[TBL] [Abstract][Full Text] [Related]
25. Keloid fibroblast responsiveness to epidermal growth factor and activation of downstream intracellular signaling pathways.
Satish L; Babu M; Tran KT; Hebda PA; Wells A
Wound Repair Regen; 2004; 12(2):183-92. PubMed ID: 15086770
[TBL] [Abstract][Full Text] [Related]
26. IP-10 inhibits epidermal growth factor-induced motility by decreasing epidermal growth factor receptor-mediated calpain activity.
Shiraha H; Glading A; Gupta K; Wells A
J Cell Biol; 1999 Jul; 146(1):243-54. PubMed ID: 10402474
[TBL] [Abstract][Full Text] [Related]
27. Epidermal growth factor receptor-mediated cell motility: phospholipase C activity is required, but mitogen-activated protein kinase activity is not sufficient for induced cell movement.
Chen P; Xie H; Sekar MC; Gupta K; Wells A
J Cell Biol; 1994 Nov; 127(3):847-57. PubMed ID: 7962064
[TBL] [Abstract][Full Text] [Related]
28. Growth stimulation of non-small cell lung cancer cell lines by antibody against epidermal growth factor receptor promoting formation of ErbB2/ErbB3 heterodimers.
Maegawa M; Takeuchi K; Funakoshi E; Kawasaki K; Nishio K; Shimizu N; Ito F
Mol Cancer Res; 2007 Apr; 5(4):393-401. PubMed ID: 17426253
[TBL] [Abstract][Full Text] [Related]
29. Epidermal growth factor-induced proliferation of chicken primordial germ cells: involvement of calcium/protein kinase C and NFKB1.
Ge C; Yu M; Petitte JN; Zhang C
Biol Reprod; 2009 Mar; 80(3):528-36. PubMed ID: 19005168
[TBL] [Abstract][Full Text] [Related]
30. Activation of the EGFR gene target EphA2 inhibits epidermal growth factor-induced cancer cell motility.
Larsen AB; Pedersen MW; Stockhausen MT; Grandal MV; van Deurs B; Poulsen HS
Mol Cancer Res; 2007 Mar; 5(3):283-93. PubMed ID: 17374733
[TBL] [Abstract][Full Text] [Related]
31. Thalidomide inhibits epidermal growth factor-induced cell growth in mouse and human monocytic leukemia cells via Ras inactivation.
Noman AS; Koide N; Khuda II; Dagvadorj J; Tumurkhuu G; Naiki Y; Komatsu T; Yoshida T; Yokochi T
Biochem Biophys Res Commun; 2008 Oct; 374(4):683-7. PubMed ID: 18662673
[TBL] [Abstract][Full Text] [Related]
32. Control of cell motility by interaction of gangliosides, tetraspanins, and epidermal growth factor receptor in A431 versus KB epidermoid tumor cells.
Park SY; Yoon SJ; Freire-de-Lima L; Kim JH; Hakomori SI
Carbohydr Res; 2009 Aug; 344(12):1479-86. PubMed ID: 19559406
[TBL] [Abstract][Full Text] [Related]
33. Proline-rich tyrosine kinase 2 (Pyk2) promotes proliferation and invasiveness of hepatocellular carcinoma cells through c-Src/ERK activation.
Sun CK; Man K; Ng KT; Ho JW; Lim ZX; Cheng Q; Lo CM; Poon RT; Fan ST
Carcinogenesis; 2008 Nov; 29(11):2096-105. PubMed ID: 18765415
[TBL] [Abstract][Full Text] [Related]
34. Mechanisms of anti-proliferative effect of JTE-522, a selective cyclooxygenase-2 inhibitor, on human liver cancer cells.
Nagahara T; Okano J; Murawaki Y
Oncol Rep; 2007 Nov; 18(5):1281-90. PubMed ID: 17914586
[TBL] [Abstract][Full Text] [Related]
35. Chemopreventive action of Lygodium flexuosum extract in human hepatoma PLC/PRF/5 and Hep 3B cells.
Wills PJ; Asha VV
J Ethnopharmacol; 2009 Mar; 122(2):294-303. PubMed ID: 19168119
[TBL] [Abstract][Full Text] [Related]
36. Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation.
Ozaki I; Zhang H; Mizuta T; Ide Y; Eguchi Y; Yasutake T; Sakamaki T; Pestell RG; Yamamoto K
Clin Cancer Res; 2007 Apr; 13(7):2236-45. PubMed ID: 17404108
[TBL] [Abstract][Full Text] [Related]
37. Prostaglandin E1 and misoprostol increase epidermal growth factor production in 3D-cultured human annulus cells.
Gruber HE; Hoelscher G; Loeffler B; Chow Y; Ingram JA; Halligan W; Hanley EN
Spine J; 2009 Sep; 9(9):760-6. PubMed ID: 19535298
[TBL] [Abstract][Full Text] [Related]
38. Heparin-binding epidermal growth factor-like growth factor promotes enterocyte migration and proliferation in neonatal rats with necrotizing enterocolitis.
Feng J; Besner GE
J Pediatr Surg; 2007 Jan; 42(1):214-20. PubMed ID: 17208569
[TBL] [Abstract][Full Text] [Related]
39. Histamine, mast cells and tumour cell proliferation in breast cancer: does preoperative cimetidine administration have an effect?
Bowrey PF; King J; Magarey C; Schwartz P; Marr P; Bolton E; Morris DL
Br J Cancer; 2000 Jan; 82(1):167-70. PubMed ID: 10638985
[TBL] [Abstract][Full Text] [Related]
40. Cimetidine induces interleukin-18 production through H2-agonist activity in monocytes.
Takahashi HK; Watanabe T; Yokoyama A; Iwagaki H; Yoshino T; Tanaka N; Nishibori M
Mol Pharmacol; 2006 Aug; 70(2):450-3. PubMed ID: 16723495
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
